Abstract

OBJECTIVES:Misuse of anabolic androgenic steroids in athletes is a strategy used to enhance strength and skeletal muscle hypertrophy. However, its abuse leads to an imbalance in muscle sympathetic nerve activity, increased vascular resistance, and increased blood pressure. However, the mechanisms underlying these alterations are still unknown. Therefore, we tested whether anabolic androgenic steroids could impair resting baroreflex sensitivity and cardiac sympathovagal control. In addition, we evaluate pulse wave velocity to ascertain the arterial stiffness of large vessels.METHODS:Fourteen male anabolic androgenic steroid users and 12 nonusers were studied. Heart rate, blood pressure, and respiratory rate were recorded. Baroreflex sensitivity was estimated by the sequence method, and cardiac autonomic control by analysis of the R-R interval. Pulse wave velocity was measured using a noninvasive automatic device.RESULTS:Mean spontaneous baroreflex sensitivity, baroreflex sensitivity to activation of the baroreceptors, and baroreflex sensitivity to deactivation of the baroreceptors were significantly lower in users than in nonusers. In the spectral analysis of heart rate variability, high frequency activity was lower, while low frequency activity was higher in users than in nonusers. Moreover, the sympathovagal balance was higher in users. Users showed higher pulse wave velocity than nonusers showing arterial stiffness of large vessels. Single linear regression analysis showed significant correlations between mean blood pressure and baroreflex sensitivity and pulse wave velocity.CONCLUSIONS:Our results provide evidence for lower baroreflex sensitivity and sympathovagal imbalance in anabolic androgenic steroid users. Moreover, anabolic androgenic steroid users showed arterial stiffness. Together, these alterations might be the mechanisms triggering the increased blood pressure in this population.

Highlights

  • Misuse of anabolic androgenic steroids (AASs) in bodybuilding athletes is a common strategy to enhance strength and skeletal muscle hypertrophy

  • There were no significant differences between AAS user (AASU) and AAS nonusers (AASNUs) in age and height

  • After controlling for cofactors, analysis of covariance (ANCOVA) showed no significant differences in MBP for age (p=0.47) or body mass index (BMI) (p=0.13)

Read more

Summary

Introduction

Misuse of anabolic androgenic steroids (AASs) in bodybuilding athletes is a common strategy to enhance strength and skeletal muscle hypertrophy. AASs are associated with negative impacts on health, such as muscle sympathetic hyperactivation, reduced vasodilatation, and increased blood pressure (BP) [1,2,3]. The exact mechanisms involved in these alterations in AAS user (AASU) athletes are still unknown. In several cardiovascular diseases such as hypertension and heart failure, lower baroreflex sensitivity (BRS) is one of the main mechanisms leading to increased sympathetic. Received for publication on June 13, 2017. Accepted for publication on November 27, 2017

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call